Teva Pharmaceutical Industries Pre-Paid Expenses 2010-2025 | TEVA
Teva Pharmaceutical Industries pre-paid expenses for the quarter ending March 31, 2025 were $1.018B, a 23.8% decline year-over-year.
- Teva Pharmaceutical Industries pre-paid expenses for 2024 were $1.006B, a 19.84% decline from 2023.
- Teva Pharmaceutical Industries pre-paid expenses for 2023 were $1.255B, a 8% increase from 2022.
- Teva Pharmaceutical Industries pre-paid expenses for 2022 were $1.162B, a 8.09% increase from 2021.